TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 786362

Group type: EXPERIMENTAL
Intervention: Busulphan
Number of subjects: 726

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Number of subjects: 726

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 726
Study: 31903692

Group type: EXPERIMENTAL
Intervention: Semaglutide
Number of subjects: 0
Study: 31601466

Group type: EXPERIMENTAL
Intervention: Bone marrow nucleated cell (BMNc) injection
Number of subjects: 30

Group type: COMPARATOR
Intervention: Hyaluronic acid (HA) injection
Number of subjects: 30
Study: 28619050

Group type: EXPERIMENTAL
Intervention: Brief Admission Skåne plus Treatment as Usual
Number of subjects: 124

Group type: COMPARATOR
Intervention: Treatment As Usual
Number of subjects: 124
Study: 24878846

Group type: EXPERIMENTAL
Intervention: Ankle-foot orthosis
Number of subjects: 0
Study: 23234617

Group type: EXPERIMENTAL
Intervention: Silodosin 8 mg daily with breakfast for 12 weeks
Number of subjects: 923

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 923

Group type: EXPERIMENTAL
Intervention: Silodosin
Number of subjects: 923
Study: 21672211

Group type: EXPERIMENTAL
Intervention: Aerobic exercise therapy (AET) + usual care
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy (CBT) + usual care
Number of subjects: 120

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 120
Study: 19419445

Group type: EXPERIMENTAL
Intervention: CAF
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: CAF+R
Number of subjects: 16
Study: 16398727

Group type: EXPERIMENTAL
Intervention: Photochemically treated (PCT) platelets
Number of subjects: 308

Group type: COMPARATOR
Intervention: Control platelets
Number of subjects: 308
Study: 15674006

Group type: EXPERIMENTAL
Intervention: Massage therapy (20 minutes, twice weekly, for 12 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Friendly visit (control group, reading, talking, playing quiet games, twice weekly for 12 weeks)
Number of subjects: 0
Study: 11207018

Group type: EXPERIMENTAL
Intervention: Supine position (group 1)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Semi-recumbent position (group 2)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Supplemental oxygen (2 l by nasal cannulae)
Number of subjects: 38
Study: 8077977

Group type: EXPERIMENTAL
Intervention: Local cryotherapy at 50 degrees F
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Local cryotherapy at 60 degrees F
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Local cryotherapy at 70 degrees F
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Patient-controlled analgesia (morphine)
Number of subjects: 90
Study: 2569600

Group type: EXPERIMENTAL
Intervention: 6 hours of normobaric oxygen (NBO) in group A0 (n = 170)
Number of subjects: 629

Group type: EXPERIMENTAL
Intervention: 2 hours of hyperbaric oxygen (HBO) at 2 ATA plus 4 hours of NBO in group A1 (n = 173)
Number of subjects: 629

Group type: EXPERIMENTAL
Intervention: 1 session of HBO in group B1 (n = 145)
Number of subjects: 629

Group type: EXPERIMENTAL
Intervention: 2 sessions of HBO in group B2 (n = 141)
Number of subjects: 629

Group type: EXPERIMENTAL
Intervention: Patients with coma (B1 and B2)
Number of subjects: 629
Study: 407788

Group type: EXPERIMENTAL
Intervention: Ad libitum dietary intake (60 to 270 cal/kg per day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dietary protein level
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Changes in dietary intake
Number of subjects: 0

Group type: COMPARATOR
Intervention: Inadequate dietary intake
Number of subjects: 0
Study: 31334466

Group type: EXPERIMENTAL
Intervention: Hemiarthroplasty
Number of subjects: 120

Group type: COMPARATOR
Intervention: Total hip arthroplasty
Number of subjects: 120
Study: 23657761

Group type: EXPERIMENTAL
Intervention: Lisdexamfetamine dimesylate (LDX)
Number of subjects: 40
Study: 26098847

Group type: EXPERIMENTAL
Intervention: ARB (40 mg/day olmesartan) for eight weeks
Number of subjects: 245
Study: 25126036

Group type: EXPERIMENTAL
Intervention: Tactile and proprioceptive sensory stimulation (condition 2)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Tactile sensory stimulation only (condition 3)
Number of subjects: 18

Group type: COMPARATOR
Intervention: No electrical stimulation (condition 1)
Number of subjects: 18
Study: 23160273

Group type: EXPERIMENTAL
Intervention: Powered discectomy device used by attending surgeons in levels 9 and 11
Number of subjects: 9

Group type: COMPARATOR
Intervention: Manual discectomy performed by spine fellows
Number of subjects: 9

Group type: COMPARATOR
Intervention: Manual discectomy performed by spine attendings
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Powered discectomy device
Number of subjects: 9
Study: 19418214

Group type: EXPERIMENTAL
Intervention: StressEraser
Number of subjects: 10

Group type: COMPARATOR
Intervention: No-treatment control
Number of subjects: 10
Study: 17717237

Group type: EXPERIMENTAL
Intervention: Transdermal scopolamine 1.5 mg
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: IV ondansetron 4 mg
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study: 15104206

Group type: EXPERIMENTAL
Intervention: Oestradiol valerate therapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Combined HRT with oestradiol valerate and levonorgestrel
Number of subjects: 30
Study: 11439290

Group type: EXPERIMENTAL
Intervention: GLP-1 infusion
Number of subjects: 18
Study: 9404675

Group type: EXPERIMENTAL
Intervention: n‐3 PUFA (5.4 g daily as ethyl esters)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: High‐Se bread (3 slices daily providing 115 micrograms Se)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo (for groups 1 and 4)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: High‐Se bread with n‐3 PUFA
Number of subjects: 31
Study: 8484499

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS) on the P6 point applied 30‐45 min before induction of anesthesia and continued for 6 h postoperatively
Number of subjects: 103

Group type: COMPARATOR
Intervention: Control group with electrical stimulator turned off
Number of subjects: 103
Study: 3040959

Group type: EXPERIMENTAL
Intervention: OrthoMatrix HA‐500
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Interpore 200
Number of subjects: 12

Group type: COMPARATOR
Intervention: Debrided control
Number of subjects: 12
Study: 29415730

Group type: EXPERIMENTAL
Intervention: Pre‐ and postnatal small‐quantity lipid‐based nutrient supplements for both mother and child
Number of subjects: 432

Group type: COMPARATOR
Intervention: Prenatal supplementation with iron and folic acid
Number of subjects: 432

Group type: COMPARATOR
Intervention: Pre‐ and postnatal supplementation with multiple micronutrients
Number of subjects: 432
Study: 27464984

Group type: EXPERIMENTAL
Intervention: IPE-27 (10 g/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IPE-54 (10 g/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Inulin (control)
Number of subjects: 0
Study: 23822141

Group type: EXPERIMENTAL
Intervention: Cross-linked collagen membrane (VN)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Native collagen membrane (CM)
Number of subjects: 19
Study: 22660367

Group type: EXPERIMENTAL
Intervention: 1-day IUC clamping
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 3-day IUC clamping
Number of subjects: 60

Group type: COMPARATOR
Intervention: 0-day IUC removal without clamping
Number of subjects: 60
Study: 20554376

Group type: EXPERIMENTAL
Intervention: Percutaneous vertebroplasty for osteoporotic burst fractures
Number of subjects: 64

Group type: COMPARATOR
Intervention: Percutaneous vertebroplasty for osteoporotic compression fractures
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Cement leakage rate
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Adjacent fractures
Number of subjects: 64
Study: 18540873

Group type: COMPARATOR
Intervention: Tissue Dielectric Constant (TDC) values at forearm and biceps
Number of subjects: 22

Group type: COMPARATOR
Intervention: TDC values at axilla, biceps, forearm, and thorax
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: TDC values at different depths in forearm
Number of subjects: 22

Group type: COMPARATOR
Intervention: Dominant-non-dominant side comparisons
Number of subjects: 22
Study: 15883282

Group type: EXPERIMENTAL
Intervention: Tacrolimus
Number of subjects: 37

Group type: COMPARATOR
Intervention: Cyclosporine
Number of subjects: 37
Study: 12670816

Group type: EXPERIMENTAL
Intervention: Epidural 10 mL saline injection
Number of subjects: 100

Group type: COMPARATOR
Intervention: No epidural injection (dry group)
Number of subjects: 100
Study: 10053175

Group type: EXPERIMENTAL
Intervention: Multicomponent intervention for delirium prevention
Number of subjects: 852

Group type: COMPARATOR
Intervention: Usual-care group (control)
Number of subjects: 852
Study: 8595991

Group type: EXPERIMENTAL
Intervention: Drug combinations for Helicobacter pylori eradication
Number of subjects: 0
Study: 1572460

Group type: EXPERIMENTAL
Intervention: Surgical thrombectomy (TE)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Thrombolysis (TL) using 30 mg rt-PA
Number of subjects: 20
Study: 3933523

Group type: EXPERIMENTAL
Intervention: Auranofin
Number of subjects: 110

Group type: COMPARATOR
Intervention: Gold sodium thiomalate
Number of subjects: 110
Study: 31392214

Group type: EXPERIMENTAL
Intervention: Overweight and obesity prevalence among Libyan adults
Number of subjects: 401
Study: 30442137

Group type: EXPERIMENTAL
Intervention: Consensus-driven CONSORT extension for randomised trials using an adaptive design
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Delphi survey
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Consensus meeting
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Abstract checklist
Number of subjects: 0
Study: 27681448

Group type: EXPERIMENTAL
Intervention: Standardized rescue exercise program conducted for 12 weeks at 3 sessions per week.
Number of subjects: 129
Study: 26210907

Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 351

Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 351

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 351
Study: 23288762

Group type: EXPERIMENTAL
Intervention: Medial Pivot (MP) prostheses
Number of subjects: 465

Group type: EXPERIMENTAL
Intervention: Anterior and Posterior Cruciate Ligament Retaining (ACL-PCL) prostheses
Number of subjects: 465

Group type: EXPERIMENTAL
Intervention: Posterior Cruciate Ligament (PCL) prostheses
Number of subjects: 465

Group type: EXPERIMENTAL
Intervention: Posterior Cruciate-Substituting (PS) prostheses
Number of subjects: 465

Group type: EXPERIMENTAL
Intervention: Mobile Bearing (MB) prostheses
Number of subjects: 465
Study: 20873910

Group type: EXPERIMENTAL
Intervention: Video teleconferencing (VTC)
Number of subjects: 112

Group type: COMPARATOR
Intervention: In-person delivery
Number of subjects: 112
Study: 19105579

Group type: EXPERIMENTAL
Intervention: STTTTTTT presentation program
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: AON learning
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Incremental learning
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Unlearned items
Number of subjects: 50
Study: 16652311

Group type: EXPERIMENTAL
Intervention: Multifaceted prevention strategy for urinary tract infection in orthopedic surgery patients
Number of subjects: 1328

Group type: COMPARATOR
Intervention: Abdominal surgery patients (control)
Number of subjects: 1328
Study: 12791814

Group type: EXPERIMENTAL
Intervention: Valsartan (40-80 mg/d)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control (ACE inhibitor and loop diuretic only)
Number of subjects: 32
Study: 11069197

Group type: EXPERIMENTAL
Intervention: 10 mg alendronate daily (group 1)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 10 mg alendronate daily (group 2)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 10 mg alendronate daily (group 1, 10 patients who did not respond to etidronate)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 10 mg alendronate daily (group 1, 15 patients who did not respond at FN to etidronate)
Number of subjects: 50
Study: 8840345

Group type: EXPERIMENTAL
Intervention: Acute cigarette smoking in young smokers
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Acute cigarette smoking in both young and elderly smokers
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Long-term smoking history
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Aging effects
Number of subjects: 40

Group type: COMPARATOR
Intervention: Smoker versus nonsmoker status
Number of subjects: 40
Study: 1611181

Group type: EXPERIMENTAL
Intervention: Ofloxacin (OFLX) plus amphotericin-B (AMPH) and polymyxin-B (PL)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control regimen with polymyxin-B (PL) and amphotericin-B (AMPH) alone
Number of subjects: 22
Study: 6203784

Group type: EXPERIMENTAL
Intervention: Serial hormone determinations (beta‐hCG, HPL, P, 17‐OHP, E2 and E3)
Number of subjects: 1125

Group type: EXPERIMENTAL
Intervention: Combined determination of all hormones
Number of subjects: 1125

Group type: EXPERIMENTAL
Intervention: Measurement of beta‐hCG
Number of subjects: 1125

Group type: EXPERIMENTAL
Intervention: Measurement of E2 or E3
Number of subjects: 1125

Group type: EXPERIMENTAL
Intervention: All methods tested
Number of subjects: 1125

Group type: EXPERIMENTAL
Intervention: Hormone determinations
Number of subjects: 1125
Study: 30827428

Group type: EXPERIMENTAL
Intervention: Early mobilization (EM); self‐weaned from sling and performed pain‐free active ROM during the first 6 weeks
Number of subjects: 206

Group type: COMPARATOR
Intervention: Standard rehabilitation (SR); wore a sling for 6 weeks with no active ROM
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Both EM and SR groups
Number of subjects: 206
Study: 30047816

Group type: EXPERIMENTAL
Intervention: Pharmaceutical Care (PC) group
Number of subjects: 153

Group type: COMPARATOR
Intervention: Usual Care (UC) group
Number of subjects: 153
Study: 26742999

Group type: EXPERIMENTAL
Intervention: SMS texting arm (n=22)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Non-SMS texting arm (n=21)
Number of subjects: 43
Study: 24220007

Group type: EXPERIMENTAL
Intervention: 3-dimensional neuroendoscopy
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: high-definition neuroendoscopy
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 3-dimensional and high-definition neuroendoscopy
Number of subjects: 10
Study: 22523306

Group type: EXPERIMENTAL
Intervention: Intracoronary injection of autologous BMNCs
Number of subjects: 183

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 183
Study: 20361674

Group type: EXPERIMENTAL
Intervention: midazolam 2 mg
Number of subjects: 80

Group type: COMPARATOR
Intervention: metoclopramide 10 mg
Number of subjects: 80
Study: 17704033

Group type: EXPERIMENTAL
Intervention: Multiple micronutrient fortified salt
Number of subjects: 129

Group type: COMPARATOR
Intervention: Control group (no fortified salt)
Number of subjects: 129
Study: 16327472

Group type: EXPERIMENTAL
Intervention: Black polyurethane (PU) foam at negative pressure of 300 mmHg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: White polyvinyl alcohol (PVA) foam at negative pressure of 300 mmHg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison of blood flow at baseline and at negative pressure of 300 mmHg
Number of subjects: 0
Study: 12402733

Group type: EXPERIMENTAL
Intervention: Esmolol 80 mg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 10087856

Group type: EXPERIMENTAL
Intervention: Processing order information in a short-term memory task
Number of subjects: 0

Group type: COMPARATOR
Intervention: Short-term memory task without processing order information
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Similar short-term memory task
Number of subjects: 0
Study: 7709938

Group type: EXPERIMENTAL
Intervention: Preventive measures for osteoporosis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Current treatments for osteoporosis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Interventions at a much later age
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Preventive treatments
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Management of osteoporosis
Number of subjects: 0
Study: 2062395

Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation (optimal medical treatment, training of physical endurance, health education, psychological and social support) for 3 months, 38 hours a week
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation
Number of subjects: 44
Study: 6409919

Group type: EXPERIMENTAL
Intervention: hpGRF44 (0.5 microgram/kg)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: hpGRF44 (5 micrograms/kg)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: hpGRF44 (10 micrograms/kg)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 30941490

Group type: EXPERIMENTAL
Intervention: Percutaneous vertebroplasty (PV)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 180
Study: 28849338

Group type: EXPERIMENTAL
Intervention: Peer network gender norms
Number of subjects: 1103

Group type: EXPERIMENTAL
Intervention: Peer network social cohesion
Number of subjects: 1103
Study: 26473996

Group type: COMPARATOR
Intervention: Control (CON; 25°C/45% RH, inspired fraction of oxygen = 20.9%)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Normobaric hypoxic (HYP; 25°C/45% RH, inspired fraction of oxygen = 13.3%/simulated altitude of 3600 m)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Normobaric hypoxic (HYP)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Hot (HOT; 38°C/21% RH, inspired fraction of oxygen = 20.9%)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: All conditions (CON, HOT, HYP)
Number of subjects: 6
Study: 24158248

Group type: EXPERIMENTAL
Intervention: Eicosapentaenoic acid (EPA) 1,800 mg daily plus statin (EPA group, n = 40)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Statin alone (Control group, n = 40)
Number of subjects: 80
Study: 22170794

Group type: EXPERIMENTAL
Intervention: Metformin treatment
Number of subjects: 111

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: NAFLD patients
Number of subjects: 111
Study: 20395860

Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Human albumin
Number of subjects: 51
Study: 18225427

Group type: EXPERIMENTAL
Intervention: Antiarrhythmic drugs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 15898479

Group type: EXPERIMENTAL
Intervention: Deprivation
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Satiation
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control
Number of subjects: 6
Study: 11870101

Group type: EXPERIMENTAL
Intervention: Immediate post-partum insertion of IUDs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lippes Loops and Progestasert devices
Number of subjects: 0

Group type: COMPARATOR
Intervention: Insertion techniques (hand vs instruments)
Number of subjects: 0
Study: 10220202

Group type: EXPERIMENTAL
Intervention: Aortic stiffness measurement using echo-tracking sonography
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Aortic stiffness measurement using echo-tracking sonography, adjusted for diabetes duration
Number of subjects: 40
Study: 8570263

Group type: EXPERIMENTAL
Intervention: Amiloride (10 mg oral dose)
Number of subjects: 8
Study: 2212182

Group type: EXPERIMENTAL
Intervention: Comprehensive community programming for drug abuse prevention (school, parent, mass media, and community organization)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control condition (mass media and community organization only)
Number of subjects: 8
Study: 7009502

Group type: EXPERIMENTAL
Intervention: Metronidazole and Kanamycin systemically
Number of subjects: 72

Group type: COMPARATOR
Intervention: Metronidazole and Kanamycin orally
Number of subjects: 72
Study: 30520977

Group type: EXPERIMENTAL
Intervention: Once-daily chemoradiotherapy (66 Gy in 33 fractions)
Number of subjects: 509

Group type: EXPERIMENTAL
Intervention: Twice-daily chemoradiotherapy (45 Gy in 30 fractions)
Number of subjects: 509

Group type: EXPERIMENTAL
Intervention: Stage I to II disease
Number of subjects: 509

Group type: COMPARATOR
Intervention: Stage III disease
Number of subjects: 509
Study: 28251321

Group type: EXPERIMENTAL
Intervention: Tramadol 2 mg/kg diluted in normal saline up to 2 cc total volume injected before surgery
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Tramadol 2 mg/kg diluted in normal saline up to 2 cc total volume injected after surgery
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Tramadol infiltration before surgery
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Tramadol infiltration after surgery
Number of subjects: 80

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 80
Study: 25733461

Group type: EXPERIMENTAL
Intervention: Whey protein isolate (WPI) with maltodextrin (MD19)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Sodium caseinate (SC) with maltodextrin (MD19)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Maltodextrin (MD19) alone
Number of subjects: 30
Study: 23998710

Group type: EXPERIMENTAL
Intervention: Apical pacing (Group A)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Septal pacing (Group S)
Number of subjects: 71
Study: 23241931

Group type: EXPERIMENTAL
Intervention: Meriva (2 tablets/day, 2 x 500 mg of Meriva/day, corresponding to 2 x 100 mg curcumin/day)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Best Standard Management (BSM) alone
Number of subjects: 61
Study: 19402344

Group type: EXPERIMENTAL
Intervention: Topical formulations containing ketoprofen
Number of subjects: 0
Study: 17451800

Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroid (ICS)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 15129311

Group type: EXPERIMENTAL
Intervention: Closed internal sphincterotomy
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Open internal sphincterotomy
Number of subjects: 79
Study: 11699613

Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg once daily for 8 days
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Rabeprazole 10 mg once daily for 8 days
Number of subjects: 15

Group type: COMPARATOR
Intervention: Lansoprazole
Number of subjects: 15

Group type: COMPARATOR
Intervention: Rabeprazole
Number of subjects: 15